Era Mandiri Cemerlang Tbk. vs Merck Tbk. — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp86 (market cap 70B, 29.46M 24h volume), while Merck Tbk. trades at Rp3,860 (market cap 1.7T, 28K 24h volume). The key difference: Merck Tbk. is far larger — about 24.3× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (29.46M versus 28K). Which is the better fit depends on your goals.
| IKAN | MERK | |
|---|---|---|
Market Cap | 70B | 1.7T |
Volume | 29.46M | 28K |
Lot | 294.64K | 280 |
Turnover | 2.53B | 107.47M |
Average Price | 85.92 | 3,838.25 |
Value | 2.53B | 107.47M |
Indicative Equilibrium Price | 84 | 3,850 |
Indicative Equilibrium Volume | 20.5K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →